Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kalpesh Joshi"'
Publikováno v:
Dubai Diabetes and Endocrinology Journal, Pp 1-8 (2021)
Introduction: The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing and is fueled by a twin-epidemic of obesity and diabetes mellitus in India. The objective of the study was to estimate various noninvasive NAFLD scores (NINS) for
Externí odkaz:
https://doaj.org/article/744181e437984e1bba4996b442bd42db
Autor:
Guiying He, Chun-Feng Liu, Qinyong Ye, Zhenguo Liu, Miao Jin, Huifang Shang, Ling Chen, Houzhen Tuo, Hong Jiang, Jifu Cai, Kalpesh Joshi, James Cooper, Lu Zi, Shengdi Chen
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The impact of nocturnal disturbance (ND) in Parkinson’s disease on quality of life of patients in Western Countries is increasingly understood. Our study aimed to investigate ND prevalence and its quality of life impact in patie
Externí odkaz:
https://doaj.org/article/3faabc9bc6c14a7baaf87ef2a459379f
Publikováno v:
Artificial Intelligence in Information and Communication Technologies, Healthcare and Education ISBN: 9781003342755
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb71a32764930903fbf0727817f6e52d
https://doi.org/10.1201/9781003342755-5
https://doi.org/10.1201/9781003342755-5
Publikováno v:
Dubai Diabetes and Endocrinology Journal, Pp 1-8 (2021)
Introduction: The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing and is fueled by a twin-epidemic of obesity and diabetes mellitus in India. The objective of the study was to estimate various noninvasive NAFLD scores (NINS) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7819049a0c26a45158ba7fd779f4864
https://www.karger.com/Article/FullText/518155
https://www.karger.com/Article/FullText/518155
Autor:
Kalpesh Joshi, Guiying He, Huifang Shang, Qinyong Ye, Miao Jin, Jifu Cai, Lu Zi, Houzhen Tuo, James Cooper, Zhenguo Liu, Hong Jiang, Chun-Feng Liu, Sheng-Di Chen, Ling Chen
Publikováno v:
BMC Neurology
BMC Neurology, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Neurology, Vol 21, Iss 1, Pp 1-9 (2021)
Background The impact of nocturnal disturbance (ND) in Parkinson’s disease on quality of life of patients in Western Countries is increasingly understood. Our study aimed to investigate ND prevalence and its quality of life impact in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9d9853deaaeed8c7ce596d7ebba0706
https://doi.org/10.1186/s12883-021-02217-5
https://doi.org/10.1186/s12883-021-02217-5
Autor:
Guiying He, Liu, Chun-Feng, Qinyong Ye, Zhenguo Liu, Jin, Miao, Huifang Shang, Chen, Ling, Houzhen Tuo, Jiang, Hong, Jifu Cai, Kalpesh Joshi, Cooper, James, Zi, Lu, Shengdi Chen
Additional file 1 Study 207,944 Nocturnal disturbances. Figure S1. Study sites. Figure S2. Patient disposition. Table S1. Item scores for PDSS-2. Table S2. Linear regression of PDQ-39 total score.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c28f30acb1ee341ee4a361c136ebd1
Publikováno v:
ITM Web of Conferences. 44:03002
Agriculture production is extremely important in today’s economy because disease development in plants is relatively common, early detection of disease in plants is critical in the agriculture field. The automatic finding of such early-stage diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fe696cc1a13f8be7604db823a747437
https://doi.org/10.1051/itmconf/20224403002
https://doi.org/10.1051/itmconf/20224403002
Autor:
Kalpesh Joshi, Mahesh Belhekar
Publikováno v:
International Journal of Clinical Trials. 7:262
Background: Hearing loss has been reported with lamivudine therapy. The World Health Organization (WHO) international database of suspected adverse drug reactions (Vigibase) prioritised clinical review of lamivudine and hearing loss in 2015. This man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee800c46f67c41c3c459a8d7036efb6c
https://doi.org/10.18203/2349-3259.ijct20204484
https://doi.org/10.18203/2349-3259.ijct20204484
Autor:
Neil Brickel, Jeni De'Ath, Karen Hewett, Kalpesh Joshi, Susan A. McDonald, Jerzy Daniluk, Olga Vorobyeva, Somsak Tiamkao, Kirsty Rayner, Marie Catherine Boll, James Cooper
Publikováno v:
Epilepsy & Behavior. 102:106580
Background Retigabine is an antiepileptic drug developed for the adjunctive treatment of adults with epilepsy and partial-onset seizures (POS). Following its approval in 2011, reports of ophthalmological/dermatological pigmentation/discoloration led
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef3e6cc79ecfdf746e3d5a6b2094aefa
https://doi.org/10.1016/j.yebeh.2019.106580
https://doi.org/10.1016/j.yebeh.2019.106580